Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
6 studies found for:    cdc7
Show Display Options
Download search resultsDownload the search results for:
cdc7 (6 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Terminated A Study of BMS-863233 in Patients With Hematologic Cancer
Condition: Refractory Hematologic Cancer
Intervention: Drug: Cdc7-inhibitor (BMS-863233)
2 Terminated A Study of BMS-863233 in Patients With Advanced and/or Metastatic Solid Tumors
Conditions: Advanced Solid Cancers;   Metastatic Cancer
Intervention: Drug: Cdc7-inhibitor
3 Not yet recruiting A CR-UK Phase I Trial of LY3143921
Conditions: a. Colorectal Cancer;   b. High Grade Serous Ovarian Cancer;   c. Non Small-cell Lung Cancer (Squamous Cell Variant);   d. Squamous Carcinoma of the Oesophagus;   e. Squamous Carcinoma of the Head and Neck (HPV Negative);   f. Urothelial Cancer;   g. Breast Cancer (Triple Negative Type);   h. Pancreatic Cancer
Intervention: Drug: LY3143921 hydrate
4 Terminated Study of NMS-1116354 in Solid Tumors
Condition: Advanced Solid Tumors
Intervention: Drug: NMS-1116354
5 Terminated Study of NMS-1116354 in Advanced/Metastatic Solid Tumors
Condition: Advanced/Metastatic Solid Tumors
Intervention: Drug: NMS-1116354
6 Recruiting A Study to Evaluate TAK-931 in Participants With Advanced Nonhematologic Tumors
Condition: Nonhematologic Neoplasms, Advanced
Intervention: Drug: TAK-931

Study has passed its completion date and status has not been verified in more than two years.